Is oncocyte (OCX) a good stock to buy?
OncoCyte has received 71.92% “outperform” votes from our community. MarketBeat's community ratings are surveys of what our community members think about OncoCyte and other stocks. Vote “Outperform” if you believe OCX will outperform the S&P 500 over the long term.
Where can I buy shares of OCX?
Shares of OCX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
What is oncocyte's stock symbol?
OncoCyte trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "OCX." Who are OncoCyte's major shareholders? OncoCyte's stock is owned by many different retail and institutional investors.
Is oncocyte efficiently growing its dividend?
OncoCyte does not have a long track record of dividend growth. In the past three months, OncoCyte insiders have not sold or bought any company stock. Only 4.06% of the stock of OncoCyte is held by insiders. 80.65% of the stock of OncoCyte is held by institutions. High institutional ownership can be a signal of strong market trust in this company.
Is OCX stock a good buy?
OncoCyte Corp (NASDAQ:OCX) The 6 analysts offering 12-month price forecasts for OncoCyte Corp have a median target of 3.13, with a high estimate of 6.00 and a low estimate of 1.25. The median estimate represents a +243.41% increase from the last price of 0.91.
Should I buy OncoCyte stock?
OncoCyte has 150.53% upside potential, based on the analysts' average price target. Can I see which stocks the top-ranking analysts are rating? Yes, go to the Analysts' Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
Should I buy or sell OncoCyte stock right now?
5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for OncoCyte in the last year. There are currently 1 hold ra...
What is OncoCyte's stock price forecast for 2022?
5 equities research analysts have issued 1-year price objectives for OncoCyte's stock. Their forecasts range from $1.40 to $6.00. On average, they...
How has OncoCyte's stock price performed in 2022?
OncoCyte's stock was trading at $1.89 at the beginning of the year. Since then, OCX shares have decreased by 37.6% and is now trading at $1.18. Vi...
How were OncoCyte's earnings last quarter?
OncoCyte Co. (NYSEAMERICAN:OCX) released its earnings results on Wednesday, May, 11th. The biotechnology company reported ($0.11) earnings per shar...
Who are OncoCyte's key executives?
OncoCyte's management team includes the following people: Mr. Ronald A. Andrews Jr. , Pres, CEO & Director (Age 62, Pay $801.84k) Mr. Mitchell S...
Who are some of OncoCyte's key competitors?
Some companies that are related to OncoCyte include Alpha Teknova (TKNO) , VolitionRx (VNRX) , VolitionRx (VNRX) , MyMD Pharmaceuticals (MYMD)...
What other stocks do shareholders of OncoCyte own?
Based on aggregate information from My MarketBeat watchlists, some companies that other OncoCyte investors own include Alibaba Group (BABA) , Bro...
What is OncoCyte's stock symbol?
OncoCyte trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "OCX."
Who are OncoCyte's major shareholders?
OncoCyte's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (5.35%), Vanguar...
Where does OncoCyte trade?
What is OncoCyte Corp?
OncoCyte trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "OCX."
What is the official website for OncoCyte?
is a molecular diagnostics company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO. The firm also offers pharmaceutical services like multi-analyte test development and clinical trial services. The company was founded in September 2009 and is headquartered in Alameda, CA.
What is the P/B ratio of OncoCyte?
The official website for OncoCyte is www.oncocyte.com.
What is the average rating of OncoCyte?
OncoCyte has a P/B Ratio of 2.14. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.
Does OncoCyte pay dividends?
OncoCyte has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.
What is OncoCyte Corporation?
OncoCyte does not currently pay a dividend.
Is OncoCyte listed on the NASDAQ?
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay.
What time do you trade in the pre market?
OncoCyte Corporation is listed on the NASDAQ as (NASDAQ:OCX).
What is market cap?
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices. Stock prices may also move more quickly in this environment.
Does market cap include convertible securities?
Market Cap (Capitalization) is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include securities convertible into the common equity securities. "Market Cap" is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). NASDAQ does not use this value to determine compliance with the listing requirements.
How many sectors are there in Zacks?
It does not include securities convertible into the common equity securities. "Market Cap" is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable).
Is ZacksTrade a separate company?
The Zacks Sector Rank assigns a rating to each of the 16 Sectors based on their average Zacks Rank.
